Skip to main content
Healthcare professional on tablet Healthcare professional on tablet

HEALTHCARE PROVIDER WEBINAR

Biologics & Biosimilars – An Overview for Healthcare Providers

In the treatment of osteoporosis, biologic and biosimiar medications may be provided as part of a treatment plan. What do healthcare providers need to know?

Join Dr. Alan Low as he shares information on Biologics & Biosimilars – An Overview for Healthcare Providers on September 5th.  Information presented will include how biologics and biosimilars work, the benefits of biosimilars and how to speak to patients about these new treatment options.

Group of health care professionals standing together

Webinar Details

Date: September 5, 2024

Time:

12:00 pm – 1:00 pm PT
1:00 pm – 2:00 pm MT
2:00 pm – 3:00 pm CT
3:00 pm – 4:00 pm ET
4:00 pm – 5:00 pm AT
4:30 pm  – 5:30 pm NT

Registration is now closed.

PRESENTER

Dr. Alan Low

Dr. Alan Low BSc.(Pharm.), Pharm D., RPh, ACPR, FCSHP, CCD

Dr. Alan Low is a Clinical Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, Care Director at MedInfuse Health, and Primary Care Pharmacist / Pharmacy Lead at BioPro Biologics Pharmacy.

He is a member of Osteoporosis Canada’s Scientific Advisory Council, Board Advisor with the GI Society and a member of the Medical Board of HealthChoicesFirst.com, a patient video education resource. Dr. Low has experience in a wide variety of health and administrative settings including direct patient care in the hospital and clinics, clinical and practice-based research, consultant in healthcare and clinical projects as well as health advocacy. Together with a nurse educator and rheumatologist, Dr. Low has coauthored “The Osteoporosis Book, 4th Edition: Bone Health”. 

In addition, he has been the Co-Editor of the Health Matters Bulletin, published articles in scientific and health journals and newsletters, and is a founding Co-Editor of the Pharmacy Management in Canada textbook.

© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001